Behrenbruch Christian

Behrenbruch Christian is listed in filings as MD & Group CEO at Telix Pharmaceuticals Limited. This profile follows SEC Form 4 activity through May 6, 2026, including purchase activity. Recent filings connect the profile to Telix Pharmaceuticals Limited (TLX). The current snapshot covers public activity from May 6, 2026. Reported amounts are shown as $497.2K to $499.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.